Grace Lee
Impact in
- Toxicology top 0.1%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Toxicology 20
- Pharmacovigilance and Adverse Drug Reactions 20
-
- SARS-CoV-2 and COVID-19 Research 20
- Infection Control in Healthcare 7
- Co-authors
- Kathleen L. Dooling (15 shared papers)Beth P. Bell (17 shared papers)Sara E. Oliver (16 shared papers)H. Keipp Talbot (15 shared papers)Megan M. Wallace (13 shared papers)Chris Van Beneden (3 shared papers)Herbert W. Clegg (2 shared papers)Michael A. Gerber (3 shared papers)
- Journals
- MMWR Morbidity and Mortality Weekly Report (24 papers)Infection Control and Hospital Epidemiology (22 papers)PEDIATRICS (21 papers)Vaccine (18 papers)Clinical Infectious Diseases (9 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Grace Lee
216 papers receiving 13.9k citations
Grace Lee's Hit Papers
Peers
Comparison fields: 5 of 126
- Applied Microbiology and Biotechnology 434
- Toxicology 699
- Health 1.3k
- Critical Care and Intensive Care Medicine 525
- Infectious Diseases 2.2k
Countries citing papers authored by Grace Lee
This map shows the geographic impact of Grace Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Lee more than expected).
Fields of papers citing papers by Grace Lee
This network shows the impact of papers produced by Grace Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Lee. The network helps show where Grace Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Grace Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 221 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2012 | 809 |
| 2 | Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection Hit paper breakdown → | 2023 | 593 |
| 3 | Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines Hit paper breakdown → | 2018 | 512 |
| 4 | 2020 | 439 | |
| 5 | Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021 Hit paper breakdown → | 2021 | 437 |
| 6 | Executive Summary: Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2012 | 406 |
| 7 | Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. | 2006 | 327 |
| 8 | 2014 | 324 | |
| 9 | 2020 | 320 | |
| 10 | 2015 | 296 | |
| 11 | 2013 | 292 | |
| 12 | Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices Hit paper breakdown → | 2019 | 264 |
| 13 | 2020 | 254 | |
| 14 | 2020 | 252 | |
| 15 | 2014 | 251 | |
| 16 | 2009 | 239 | |
| 17 | Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update Hit paper breakdown → | 2022 | 200 |
| 18 | 2014 | 195 | |
| 19 | 2012 | 183 | |
| 20 | Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 Hit paper breakdown → | 2022 | 179 |
About Grace Lee
Grace Lee is a scholar working on Toxicology, Infectious Diseases, Epidemiology, Health and Applied Microbiology and Biotechnology, having authored 221 papers that have together received 14.8k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (20 papers), SARS-CoV-2 and COVID-19 Research (20 papers), Pneumonia and Respiratory Infections (14 papers), Vaccine Coverage and Hesitancy (11 papers), Influenza Virus Research Studies (8 papers), Bacterial Infections and Vaccines (8 papers), Nosocomial Infections in ICU (7 papers) and Infection Control in Healthcare (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (434 citations), Toxicology (699 citations), Health (1.3k citations), Critical Care and Intensive Care Medicine (525 citations) and Infectious Diseases (2.2k citations). Grace Lee has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Kathleen L. Dooling, Beth P. Bell, Sara E. Oliver, H. Keipp Talbot, Megan M. Wallace, Chris Van Beneden, Herbert W. Clegg, Michael A. Gerber, Alan L. Bisno and Edward L. Kaplan. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report, Infection Control and Hospital Epidemiology, PEDIATRICS, Vaccine and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.